Publications by authors named "Bihter Atil"

Claim this Profile
I
In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin.
Bihter Atil, Evelyn Berger-Sieczkowski, Johanna Bardy, Martin Werner, Martin Hohenegger

Naunyn Schmiedebergs Arch Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells.
Christoph Minichsdorfer, Christine Wasinger, Evelyn Sieczkowski, Bihter Atil, Martin Hohenegger

Melanoma Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo.
Petra Heffeter, Bihter Atil, Kushtrim Kryeziu, Diana Groza, Gunda Koellensperger

Eur J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.
Martin Werner, Bihter Atil, Evelyn Sieczkowski, Peter Chiba, Martin Hohenegger

Naunyn Schmiedebergs Arch Pharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.
Petra Heffeter, Katharina Böck, Bihter Atil, Mir Ali Reza Hoda, Wilfried Körner

J Biol Inorg Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis